Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)
Clinical trial NCT02586350 · COMPLETED
Trial details
- NCT number
- NCT02586350
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-09-30
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.